Zurueck zur Suche

Reporte zur Charge N3755

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

26Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
FL 3 CA 3 DC 3 WI 2 NC 2 IL 2 KY 2 DE 1 PA 1 TN 1 MN 1

VAERS 2336057

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

schwer
Staat
WI
Alter
70,0
Geschlecht
M
Eingang
27.06.2022
Impfdatum
19.04.2022
Beginn
20.04.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Electrocardiogram Fatigue Head injury Syncope X-ray

Symptomtext

Patient's wife reported the adverse event to me today 6/27/22 along with her husband. Patient received both Pfizer 2nd booster and Shingrix in left arm at approximately 4 pm 4/19/22. When he woke up in the morning 4/20/22 when walking from bedroom to the kitchen he fainted and hit his head. I was not dehydrated. They called 911 and was taken to the Emergency Room. The ER doctor did an EKG and xrays and they didn't find any other cause for the syncope. The MD said it was not a good idea to get shingrix and covid vaccines in the same day. The patient was discharged from the ER 3 hours later. The patient was a little tired the next couple of days. Did not have a concussion and no further problems reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
EKG and X-rays 4/20/22
Aktuelle Erkrankungen
not ill at the time
Vorgeschichte
CHF, has had 2 strokes, COPD, asthma, " history of broken bones with many screws and hardware in his knees."
Andere Medikamente
Eliquis, Atorvastatin, aspirin, metoprolol. No other OTC or herbal supplements.
Allergien
Sulfa antibiotics, penicillins
Vorherige Impfungen
-

VAERS 2192661

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

schwer
Staat
DE
Alter
72,0
Geschlecht
F
Eingang
22.03.2022
Impfdatum
21.03.2022
Beginn
22.03.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Fall Jaw fracture Loss of consciousness Suture insertion

Symptomtext

Patient was helping husband make breakfast in morning (one day post-vaccine) and suffered a moment of unconsciousness resulting in the patient hitting her face and fracturing her jaw in 2 places. She was taken to the emergency department where she received stitches and prescriptions for an antibiotic and pain medication. The hospital could not find any other root cause of the fall and the only new factor in the patient's life was the vaccine. Hospital is unsure if this is what caused it but cannot rule it out.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
Unknown - was seen in hospital 3/22/22 and discharged with pain medication and antibiotic
Aktuelle Erkrankungen
None
Vorgeschichte
No know HC
Andere Medikamente
None pt made RPH aware of
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2246038

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

moderat
Staat
FL
Alter
64,0
Geschlecht
M
Eingang
29.04.2022
Impfdatum
12.04.2022
Beginn
12.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Muscle spasms Tremor Vibratory sense increased

Symptomtext

severe muscle spasm; entire body violently shaking; This case was reported by a consumer via call center representative and described the occurrence of muscle spasm in a 64-year-old male patient who received Herpes zoster (Shingrix) (batch number N3755, expiry date 26th June 2023) for prophylaxis. On 12th April 2022, the patient received the 1st dose of Shingrix. On 12th April 2022 15:00, less than a day after receiving Shingrix, the patient experienced muscle spasm and shaking. On an unknown date, the outcome of the muscle spasm and shaking were recovered/resolved. It was unknown if the reporter considered the muscle spasm and shaking to be related to Shingrix. Additional Information: GSK receipt date: 21-Apr-2022 Reporter's comment: The patient called and stated that he had his first dose of Shingrix in the morning and he laid down for a nap and woke up at 3 pm experiencing his entire body violently shaking and had sever muscle spasms. Gave medical disclaimer. Referred to health care professional. Spoken as per package insert and content. Consented to follow-up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2246038

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge n3755

moderat
Staat
FL
Alter
64,0
Geschlecht
M
Eingang
29.04.2022
Impfdatum
12.04.2022
Beginn
12.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Muscle spasms Tremor Vibratory sense increased

Symptomtext

severe muscle spasm; entire body violently shaking; This case was reported by a consumer via call center representative and described the occurrence of muscle spasm in a 64-year-old male patient who received Herpes zoster (Shingrix) (batch number N3755, expiry date 26th June 2023) for prophylaxis. On 12th April 2022, the patient received the 1st dose of Shingrix. On 12th April 2022 15:00, less than a day after receiving Shingrix, the patient experienced muscle spasm and shaking. On an unknown date, the outcome of the muscle spasm and shaking were recovered/resolved. It was unknown if the reporter considered the muscle spasm and shaking to be related to Shingrix. Additional Information: GSK receipt date: 21-Apr-2022 Reporter's comment: The patient called and stated that he had his first dose of Shingrix in the morning and he laid down for a nap and woke up at 3 pm experiencing his entire body violently shaking and had sever muscle spasms. Gave medical disclaimer. Referred to health care professional. Spoken as per package insert and content. Consented to follow-up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2213156

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge n3755

moderat
Staat
NC
Alter
52,0
Geschlecht
M
Eingang
02.04.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Angina pectoris Arthralgia Mobility decreased Pain Pain in extremity Swelling

Symptomtext

Patient received that vaccine on 4/1/22 at 2:30 pm. Patient reports onset of pain around 5:30pm. Patient describes pain in shoulder, arm, and pectoris area. Patient reports arm movement limitation and shoulder swelling. Pain is somewhat relieved by OTC Ibuprofen. Patient intends to see PCP provider on 4/4/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
VitD
Allergien
prednisone (causes anxieity)
Vorherige Impfungen
-

VAERS 2698643

UNKNOWN MANUFACTURER · ZOSTER (NO BRAND NAME) · Charge N3755

mild
Staat
-
Alter
-
Geschlecht
F
Eingang
19.10.2023
Impfdatum
15.03.2022
Beginn
14.09.2023
Tage bis Beginn
548,0
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain Back pain Herpes zoster Pain Sensitive skin Vaccination failure

Symptomtext

Suspected vaccination failure; Shingles; burning throbbing pain in the right lower back radiating to the right abdomen; hypersensitivity of the skin in this area; This serious case was reported by a consumer and described the occurrence of vaccination failure in a 69-year-old female patient who received Herpes zoster (Shingles vaccine) (batch number L63B4, expiry date 08-APR-2023) for prophylaxis. Co-suspect products included Herpes zoster (Shingles vaccine) (batch number N3755) for prophylaxis. Concurrent medical conditions included diabetes, hypertension, hyperlipidemia, hypothyroidism and peripheral vascular disease. Concomitant products included metformin, valsartan, bisoprolol fumarate, rosuvastatin, levothyroxine, cilostazol (Pletal) and clopidogrel bisulfate (Plavix). On 26-JUN-2022, the patient received the 2nd dose of Shingles vaccine 50 ug. On 15-MAR-2022, the patient received the 1st dose of Shingles vaccine 50 ug. On 14-SEP-2023, 445 days after receiving Shingles vaccine and 548 days after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles), pain (Verbatim: burning throbbing pain in the right lower back radiating to the right abdomen) and hypersensitivity (Verbatim: hypersensitivity of the skin in this area). The patient was treated with methylprednisolone (Medrol) and valaciclovir hydrochloride (Valtrex). The outcome of the vaccination failure was unknown and the outcome of the shingles, pain and hypersensitivity were not resolved. It was unknown if the reporter considered the vaccination failure, shingles, pain and hypersensitivity to be related to Shingles vaccine and Shingles vaccine. It was unknown if the company considered the vaccination failure, shingles, pain and hypersensitivity to be related to Shingles vaccine and Shingles vaccine. Additional Information: GSK Receipt Date: 12-OCT-2023 This report was submitted via the online direct entry reporting system. The patient was not pregnant. The patient self-reported this case. The patient received other products concomitantly. The patient received Shingrix and had burning throbbing pain in the right lower back radiating to the right abdomen with hypersensitivity of the skin in this area and shingles. The patient had no rash. The symptoms were treated with Medrol dosepack and currently on Valtrex for almost a week. The symptoms began from 14-SEP-2023 and still ongoing. The symptoms were treated. This case was considered as suspected vaccination failure since the details regarding laboratory test confirming shingles were unknown at the time of reporting.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Diabetes; Hyperlipidemia; Hypertension; Hypothyroidism; Peripheral vascular disease
Vorgeschichte
-
Andere Medikamente
METFORMIN; VALSARTAN; BISOPROLOL FUMARATE; ROSUVASTATIN; LEVOTHYROXINE; PLETAL; PLAVIX
Allergien
-
Vorherige Impfungen
-

VAERS 2476576

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

mild
Staat
FL
Alter
68,0
Geschlecht
F
Eingang
12.10.2022
Impfdatum
03.10.2022
Beginn
04.10.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Diarrhoea Fatigue Headache Lymphadenopathy Myalgia

Symptomtext

Muscle soreness; Headache; Diarrhea; Tiredness; Swollen lymph nodes in armpit; This case was reported by a consumer via call center representative and described the occurrence of muscle soreness in a 68-year-old female patient who received Herpes zoster (Shingrix) (batch number N3755, expiry date 26th June 2023) for prophylaxis. Previously administered products included Shingrix with an associated reaction of pain in extremity (1st dose was received on Jun 2022, refer case US2022AMR142462). On 3rd October 2022, the patient received the 2nd dose of Shingrix. On 4th October 2022, 1 days after receiving Shingrix, the patient experienced muscle soreness, headache, diarrhea, tiredness and axillary lymph nodes enlarged. On an unknown date, the outcome of the muscle soreness, headache, diarrhea, tiredness and axillary lymph nodes enlarged were not recovered/not resolved. It was unknown if the reporter considered the muscle soreness, headache, diarrhea, tiredness and axillary lymph nodes enlarged to be related to Shingrix. Linked case(s) involving the same patient: US2022AMR142462 Additional Information: GSK Receipt Date: 04-Oct-2022 Reporter's comment: The patient self-reported this case. The patient received the second dose of Shingrix and experienced muscle soreness, headache, diarrhea, tiredness, and swollen lymph nodes in armpit. The reporter consent to follow-up.; Sender's Comments: US-GSK-US2022AMR142462:Same reporter

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2290803

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge n3755

mild
Staat
CA
Alter
50,0
Geschlecht
F
Eingang
23.05.2022
Impfdatum
10.03.2022
Beginn
11.03.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abdominal pain upper Back pain Chills Fatigue Headache Hyperhidrosis Myalgia Nausea Pain Peripheral coldness Pyrexia Rash Rash erythematous Retching Tunnel vision Vomiting

Symptomtext

woke 6am on 3/11/22 with shivers, cold hands/feet, sore muscles throughout body, nausea, fever of 99.1. After rising, immediately started sweating, tunnel vision and threw up 3X. Dry heaves continued for 3-4 mins, along with extremely painful stomach cramps and back ache. Eventually subsided, ate 1/2 banana and water along with 3 ibuprofen. Slept approximately 2 hours. Woke with headache, but no fever. At 3pm, fever was 102.1, chills again. Eventually subsided to just fatigue, soreness, headache rest of day/eve. 3/12/22 - woke with red bump rash on neck, chest, stomach, groin, back. - Fever gone.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain upper
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
Hashimoto's thyroid disease
Andere Medikamente
Armour Thyroid 90 mg
Allergien
Latex
Vorherige Impfungen
-

VAERS 2284844

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

mild
Staat
CA
Alter
60,0
Geschlecht
F
Eingang
19.05.2022
Impfdatum
11.05.2022
Beginn
12.05.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site induration Injection site pain Similar reaction on previous exposure to drug

Symptomtext

Both arms red and tender localized at injection site. Left arm with mild induration at injection site. Per patient redness and tenderness were resolving compared to site condition the first two days post vaccination. No concerns of skin infection at this time; per patient local and similar reactions happened before with other vaccines including prior doses of Pfizer covid19.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
pre diabetes per patient
Vorgeschichte
allergic rhinitis
Andere Medikamente
famotidine sucralfate voltaren acetaminophen
Allergien
NKA
Vorherige Impfungen
Pfizer COVID19, influenza, varicella

VAERS 2249484

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

mild
Staat
PA
Alter
83,0
Geschlecht
M
Eingang
23.04.2022
Impfdatum
22.04.2022
Beginn
23.04.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Dementia Fatigue Gait disturbance

Symptomtext

Patient feeling fatigued, unable to walk easily, patient also has dementia which could be causing the issue

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2246405

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

mild
Staat
IL
Alter
67,0
Geschlecht
F
Eingang
21.04.2022
Impfdatum
07.04.2022
Beginn
10.04.2022
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash Urticaria

Symptomtext

Patient developed rash/hives beginning 3-4 days following receiving both Shingrix & Boostrix but she also started taking gabapentin for the first time that day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Lovastatin, metoprolol, gabapentin, lisiniopril, omeprazole, hydrochlorothiazide, metoclopramide, verapamil, metoprolol, symbicort, albuterol
Allergien
-
Vorherige Impfungen
-

VAERS 2209521

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge n3755

mild
Staat
TN
Alter
66,0
Geschlecht
F
Eingang
31.03.2022
Impfdatum
29.03.2022
Beginn
31.03.2022
Tage bis Beginn
2,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site swelling Injection site warmth

Symptomtext

Patient presented with redness/swelling/pain at the injection site that was hot to the touch

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2728688

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

gering
Staat
-
Alter
56,0
Geschlecht
M
Eingang
29.12.2023
Impfdatum
09.05.2022
Beginn
09.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Unevaluable event

Symptomtext

None stated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Unevaluable event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2728525

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

gering
Staat
-
Alter
50,0
Geschlecht
F
Eingang
29.12.2023
Impfdatum
04.05.2022
Beginn
04.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Vaccine was frozen instead of frigerated

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2728142

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

gering
Staat
DC
Alter
50,0
Geschlecht
F
Eingang
28.12.2023
Impfdatum
30.11.2021
Beginn
30.11.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

VACCINE WAS FROZEN INSTEAD OF REFRIGERATED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2727666

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

gering
Staat
DC
Alter
67,0
Geschlecht
M
Eingang
27.12.2023
Impfdatum
30.03.2022
Beginn
30.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

VACCINE FROZEN INSTEAD OF REFRIGERATED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2727612

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

gering
Staat
DC
Alter
58,0
Geschlecht
F
Eingang
27.12.2023
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

VACINE FROZEN INSTEAD OF REFRIGERATED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2724917

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

gering
Staat
-
Alter
69,0
Geschlecht
F
Eingang
18.12.2023
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

VACCINE FROZEN INSTEAD OF REFRIGERATED

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2724397

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

gering
Staat
-
Alter
50,0
Geschlecht
M
Eingang
15.12.2023
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Vaccine was frozen instead of refrigerated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2374249

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

gering
Staat
MN
Alter
61,0
Geschlecht
M
Eingang
19.07.2022
Impfdatum
21.06.2022
Beginn
01.06.2022
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Hypoaesthesia

Symptomtext

Patient says his arm is numb at times from elbow to shoulder but also says he has been lifting 5 gallon pail fulls of water or material and that probably has something to do with it.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypoaesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
diabetes
Vorgeschichte
diabetes
Andere Medikamente
warfarin, glipizide,lovastatin
Allergien
nka
Vorherige Impfungen
-

VAERS 2306926

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

gering
Staat
IL
Alter
65,0
Geschlecht
F
Eingang
02.06.2022
Impfdatum
26.05.2022
Beginn
27.05.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Axillary mass Skin reaction Vaccination site mass

Symptomtext

She had a red hot lump under her left arm along with a lump on her arm where the vaccine was administered. These symptoms lasted for 3-4 days

Weitere VAERSDATA-Felder
Praegender Schweregrund
Axillary mass
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2257815

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

gering
Staat
CA
Alter
57,0
Geschlecht
M
Eingang
29.04.2022
Impfdatum
03.03.2022
Beginn
04.03.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Herpes zoster Ophthalmic herpes zoster

Symptomtext

The day after receiving the Shingrix vaccine, symptoms of shingles in my right eye began to appear. Within less than a week Dr diagnosed it as shingles. She prescribed Valacyclovir, Prednisolone Ac 1% Eye Drop, Gabapentin, Ibuprofen, Acetaminophen. The incredibly intense pain lasted 6 weeks.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Herpes zoster
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Ashwaghanda
Allergien
Fish
Vorherige Impfungen
-

VAERS 2237204

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

gering
Staat
KY
Alter
65,0
Geschlecht
M
Eingang
16.04.2022
Impfdatum
07.04.2022
Beginn
07.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental underdose

Symptomtext

patient did not receive the full dose; This case was reported by a pharmacist via call center representative and described the occurrence of accidental underdose in a 65-year-old male patient who received Herpes zoster (Shingrix) (batch number N3755, expiry date 26th June 2023) for prophylaxis. On 7th April 2022, the patient received Shingrix (intramuscular) .5 ml. On 7th April 2022, unknown after receiving Shingrix, the patient experienced accidental underdose. On an unknown date, the outcome of the accidental underdose was unknown. Additional Information: GSK Receipt Date: 07-Apr-2022 Reporter's Comments: The reporter stated that while administering the Shingrix vaccine there was an issue with the syringe and the patient did not receive the full dose of Shingrix. The reorter did not have patient's Healthcare professionals information. The reporter did not consent to follow-up. Additional Supportive Information: The patient did not receive the full dose of Shingrix, which led to accidental underdose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental underdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223157

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge n3755

gering
Staat
KY
Alter
65,0
Geschlecht
M
Eingang
08.04.2022
Impfdatum
08.04.2022
Beginn
08.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered Needle issue

Symptomtext

When technician was administering the dose needle retracted prematurely outside of the arm and patient did not receive the whole dose. contacted gsk/shingrix manufacturer and anything less than <0.45ml is and invalid dose and CDC recommends revaccination with an underrage the same day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
unknown
Allergien
nkda
Vorherige Impfungen
-

VAERS 2196302

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge n3755

gering
Staat
WI
Alter
75,0
Geschlecht
F
Eingang
24.03.2022
Impfdatum
23.03.2022
Beginn
24.03.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Defaecation urgency Proctalgia

Symptomtext

Patient called on 03/24/22 to pharmacy and stated that she had defecated in the bed over the night twice and also complained of rectal pain that started overnight as well. she states that she intends to go to the er today, but wanted to call us first to let us know.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Defaecation urgency
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none known
Vorgeschichte
none stated
Andere Medikamente
None Known
Allergien
Statin allergy
Vorherige Impfungen
-

VAERS 2191290

GLAXOSMITHKLINE BIOLOGICALS · ZOSTER (SHINGRIX) · Charge N3755

gering
Staat
NC
Alter
55,0
Geschlecht
M
Eingang
22.03.2022
Impfdatum
16.03.2022
Beginn
16.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect dose administered Product preparation issue

Symptomtext

Patient received only the adjuvant; Patient received only the adjuvant; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 55-year-old male patient who received Herpes zoster (Shingrix) (batch number N3755, expiry date 26th June 2023) for prophylaxis. On 16th March 2022, the patient received Shingrix. On 16th March 2022, unknown after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered and inappropriate preparation of medication. On an unknown date, the outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were unknown. Additional details were provided as follows: The Medical assistant reported that the patient received only the adjuvant of Shingrix, which led to inappropriate dose of vaccine administered and inappropriate preparation of medication. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-